Roth MKM analyst Richard Baldry initiated coverage of Forian with a Buy rating and $5 price target. The firm, which calls Forian’s healthcare data-centric platform “a uniquely valuable Cloud Data Services franchise,” believes its recurring revenue model offers investors an attractive combination of organic growth and scaling profitability.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FORA: